1. Reich DS, Lucchinetti CF, Calabresi PA: Multiple Sclerosis. N Engl J Med 2018, 378:169-180.
2. Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O: Multiple sclerosis. Lancet 2018, 391:1622-1636.
3. McGinley MP, Goldschmidt CH, Rae-Grant AD: Diagnosis and Treatment of Multiple Sclerosis: A Review. JAMA 2021, 325:765-779.
4. Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA: Multiple sclerosis. Nat Rev Dis Primers 2018, 4:43.
5. Ben-Nun A, Kaushansky N, Kawakami N, Krishnamoorthy G, Berer K, Liblau R, Hohlfeld R, Wekerle H: From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development. J Autoimmun 2014, 54:33-50.
6. Nylander A, Hafler DA: Multiple sclerosis. J Clin Invest 2012, 122:1180-1188.
7. Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, Hipkiss EL, Getnet D, Goldberg MV, Maris CH, et al: Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 2007, 179:4313-4317.
8. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J: A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 2001, 194:669-676.
9. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA: Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994, 179:973-984.
10. Tompkins SM, Padilla J, Dal Canto MC, Ting JP, Van Kaer L, Miller SD: De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J Immunol 2002, 168:4173-4183.
11. Fischer HG, Bonifas U, Reichmann G: Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii. J Immunol 2000, 164:4826-4834.
12. Fischer HG, Reichmann G: Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol 2001, 166:2717-2726.
13. Serafini B, Columba-Cabezas S, Di Rosa F, Aloisi F: Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am J Pathol 2000, 157:1991-2002.
14. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp M: CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99:23-33.
15. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM: Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 2001, 193:713-726.
16. Pashenkov M, Teleshova N, Kouwenhoven M, Kostulas V, Huang YM, Soderstrom M, Link H: Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis. Clin Exp Immunol 2002, 127:519-526.
17. Trebst C, Sorensen TL, Kivisakk P, Cathcart MK, Hesselgesser J, Horuk R, Sellebjerg F, Lassmann H, Ransohoff RM: CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol 2001, 159:1701-1710.
18. Abadier M, Haghayegh Jahromi N, Cardoso Alves L, Boscacci R, Vestweber D, Barnum S, Deutsch U, Engelhardt B, Lyck R: Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier. Eur J Immunol 2015, 45:1043-1058.
19. Jain P, Coisne C, Enzmann G, Rottapel R, Engelhardt B: Alpha4beta1 integrin mediates the recruitment of immature dendritic cells across the blood-brain barrier during experimental autoimmune encephalomyelitis. J Immunol 2010, 184:7196-7206.
20. Karman J, Ling C, Sandor M, Fabry Z: Initiation of immune responses in brain is promoted by local dendritic cells. J Immunol 2004, 173:2353-2361.
21. Xue Z, Li W, Wang H, Huang B, Ge Z, Gu C, Liu Y, Zhang K, Yang J, Han R, et al: ZSTK474, a novel PI3K inhibitor, modulates human CD14+ monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis. J Mol Med (Berl) 2014, 92:1057-1068.
22. Zhang K, Ge Z, Da Y, Wang D, Liu Y, Xue Z, Li Y, Li W, Zhang L, Wang H, et al: Plumbagin suppresses dendritic cell functions and alleviates experimental autoimmune encephalomyelitis. J Neuroimmunol 2014, 273:42-52.
23. Atanasov AG, Zotchev SB, Dirsch VM, International Natural Product Sciences T, Supuran CT: Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 2021, 20:200-216.
24. Li J, Li J, Zhang F: The immunoregulatory effects of Chinese herbal medicine on the maturation and function of dendritic cells. J Ethnopharmacol 2015, 171:184-195.
25. Song YC, Huang HC, Chang CY, Lee HJ, Liu CT, Lo HY, Ho TY, Lin WC, Yen HR: A Potential Herbal Adjuvant Combined With a Peptide-Based Vaccine Acts Against HPV-Related Tumors Through Enhancing Effector and Memory T-Cell Immune Responses. Front Immunol 2020, 11:62.
26. Lee CT, Huang KS, Shaw JF, Chen JR, Kuo WS, Shen G, Grumezescu AM, Holban AM, Wang YT, Wang JS, et al: Trends in the Immunomodulatory Effects of Cordyceps militaris: Total Extracts, Polysaccharides and Cordycepin. Front Pharmacol 2020, 11:575704.
27. Cunningham KG, Manson W, Spring FS, Hutchinson SA: Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) Link. Nature 1950, 166:949.
28. Lee H-P, Wu Y-C, Chen B-C, Liu S-C, Li T-M, Huang W-C, Hsu C-J, Tang C-H: Soya-cerebroside reduces interleukin production in human rheumatoid arthritis synovial fibroblasts by inhibiting the ERK, NF-κB and AP-1 signalling pathways. Food and Agricultural Immunology 2020, 31:740-750.
29. Das G, Shin HS, Leyva-Gomez G, Prado-Audelo MLD, Cortes H, Singh YD, Panda MK, Mishra AP, Nigam M, Saklani S, et al: Cordyceps spp.: A Review on Its Immune-Stimulatory and Other Biological Potentials. Front Pharmacol 2020, 11:602364.
30. Cheng C, Zhu X: Cordycepin mitigates MPTP-induced Parkinson's disease through inhibiting TLR/NF-kappaB signaling pathway. Life Sci 2019, 223:120-127.
31. Kim H, Naura AS, Errami Y, Ju J, Boulares AH: Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP. Mol Med 2011, 17:893-900.
32. Jia Y, Li H, Bao H, Zhang D, Feng L, Xiao Y, Zhu K, Hou Y, Luo S, Zhang Y, et al: Cordycepin (3'-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination. Int Immunopharmacol 2019, 75:105777.
33. Wei P, Wang K, Luo C, Huang Y, Misilimu D, Wen H, Jin P, Li C, Gong Y, Gao Y: Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury. J Neuroinflammation 2021, 18:137.
34. Song YC, Liu SJ: A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms. Sci Rep 2015, 5:12578.
35. Stromnes IM, Goverman JM: Active induction of experimental allergic encephalomyelitis. Nat Protoc 2006, 1:1810-1819.
36. O'Neill LA, Golenbock D, Bowie AG: The history of Toll-like receptors - redefining innate immunity. Nat Rev Immunol 2013, 13:453-460.
37. Chen BJ, Chen Y, Cui X, Fidler JM, Chao NJ: Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model. Transplantation 2002, 73:115-121.
38. Chen X, Murakami T, Oppenheim JJ, Howard OM: Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking. Blood 2005, 106:2409-2416.
39. Kim JY, Kang JS, Kim HM, Ryu HS, Kim HS, Lee HK, Kim YJ, Hong JT, Kim Y, Han SB: Inhibition of bone marrow-derived dendritic cell maturation by glabridin. Int Immunopharmacol 2010, 10:1185-1193.
40. Wang J, Lu J, Lan Y, Zhou H, Li W, Xiang M: Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways. J Ethnopharmacol 2013, 146:379-392.
41. Xiang M, Lu J, Zhang C, Lan Y, Zhou H, Li X, Peng W: Identification and quantification of total coumarins from Urtica dentata Hand and its roles in promoting immune tolerance via TLR4-mediated dendritic cell immaturation. Biosci Biotechnol Biochem 2013, 77:1200-1206.
42. Qin X, Jiang X, Jiang X, Wang Y, Miao Z, He W, Yang G, Lv Z, Yu Y, Zheng Y: Micheliolide inhibits LPS-induced inflammatory response and protects mice from LPS challenge. Sci Rep 2016, 6:23240.
43. Sheng KC, Pietersz GA, Tang CK, Ramsland PA, Apostolopoulos V: Reactive oxygen species level defines two functionally distinctive stages of inflammatory dendritic cell development from mouse bone marrow. J Immunol 2010, 184:2863-2872.
44. Reis e Sousa C: Dendritic cells in a mature age. Nat Rev Immunol 2006, 6:476-483.
45. Cui LY, Chu SF, Chen NH: The role of chemokines and chemokine receptors in multiple sclerosis. Int Immunopharmacol 2020, 83:106314.
46. Bogie JF, Stinissen P, Hendriks JJ: Macrophage subsets and microglia in multiple sclerosis. Acta Neuropathol 2014, 128:191-213.
47. Bartholomaus I, Kawakami N, Odoardi F, Schlager C, Miljkovic D, Ellwart JW, Klinkert WE, Flugel-Koch C, Issekutz TB, Wekerle H, Flugel A: Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009, 462:94-98.
48. Steiner O, Coisne C, Cecchelli R, Boscacci R, Deutsch U, Engelhardt B, Lyck R: Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium. J Immunol 2010, 185:4846-4855.
49. Avolio C, Ruggieri M, Cafforio P, Giuliani F, Silvestris F, Dammacco F, Livrea P, Trojano M: LFA-1 expression on CD4(+)CD45RO(+) peripheral blood T-lymphocytes in RR MS: effects induced by rIFNbeta-1a. J Neurol Sci 2001, 186:65-73.
50. Cayrol R, Wosik K, Berard JL, Dodelet-Devillers A, Ifergan I, Kebir H, Haqqani AS, Kreymborg K, Krug S, Moumdjian R, et al: Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol 2008, 9:137-145.
51. Ifergan I, Kebir H, Alvarez JI, Marceau G, Bernard M, Bourbonniere L, Poirier J, Duquette P, Talbot PJ, Arbour N, Prat A: Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on alpha4 integrin. Brain 2011, 134:3560-3577.
52. Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, Sallusto F: C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009, 10:514-523.
53. Seguin R, Biernacki K, Rotondo RL, Prat A, Antel JP: Regulation and functional effects of monocyte migration across human brain-derived endothelial cells. J Neuropathol Exp Neurol 2003, 62:412-419.
54. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A: Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007, 13:1173-1175.
55. Becher B, Spath S, Goverman J: Cytokine networks in neuroinflammation. Nat Rev Immunol 2017, 17:49-59.
56. Yong VW, Zabad RK, Agrawal S, Goncalves Dasilva A, Metz LM: Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators. J Neurol Sci 2007, 259:79-84.
57. Koper OM, Kaminska J, Sawicki K, Kemona H: CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration. Adv Clin Exp Med 2018, 27:849-856.
58. Skundric DS, Cruikshank WW, Drulovic J: Role of IL-16 in CD4+ T cell-mediated regulation of relapsing multiple sclerosis. J Neuroinflammation 2015, 12:78.
59. Mehling M, Johnson TA, Antel J, Kappos L, Bar-Or A: Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. Neurology 2011, 76:S20-27.
60. Spampinato SF, Obermeier B, Cotleur A, Love A, Takeshita Y, Sano Y, Kanda T, Ransohoff RM: Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli? PLoS One 2015, 10:e0133392.
61. Foster CA, Mechtcheriakova D, Storch MK, Balatoni B, Howard LM, Bornancin F, Wlachos A, Sobanov J, Kinnunen A, Baumruker T: FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol 2009, 19:254-266.
62. Luhder F, Kebir H, Odoardi F, Litke T, Sonneck M, Alvarez JI, Winchenbach J, Eckert N, Hayardeny L, Sorani E, et al: Laquinimod enhances central nervous system barrier functions. Neurobiol Dis 2017, 102:60-69.
63. Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O'Connor PW, International Natalizumab Multiple Sclerosis Trial G: A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003, 348:15-23.
64. Bachiller S, Jimenez-Ferrer I, Paulus A, Yang Y, Swanberg M, Deierborg T, Boza-Serrano A: Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response. Front Cell Neurosci 2018, 12:488.
65. Musella A, Gentile A, Rizzo FR, De Vito F, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, et al: Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions. Front Aging Neurosci 2018, 10:238.
66. Lei J, Wei Y, Song P, Li Y, Zhang T, Feng Q, Xu G: Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammation and oxidative stress. Eur J Pharmacol 2017, 818:110-114.
67. Effendi WI, Nagano T, Kobayashi K, Nishimura Y: Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases. Cells 2020, 9.
68. Cao HL, Liu ZJ, Chang Z: Cordycepin induces apoptosis in human bladder cancer cells via activation of A3 adenosine receptors. Tumour Biol 2017, 39:1010428317706915.
69. Chen Y, Yang SH, Hueng DY, Syu JP, Liao CC, Wu YC: Cordycepin induces apoptosis of C6 glioma cells through the adenosine 2A receptor-p53-caspase-7-PARP pathway. Chem Biol Interact 2014, 216:17-25.